Asthma therapy: how far have we come, why did we fail and where should we go next?

Janssen L. J.

Source: Eur Respir J 2009; 33: 11-20
Journal Issue: January
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Janssen L. J.. Asthma therapy: how far have we come, why did we fail and where should we go next?. Eur Respir J 2009; 33: 11-20

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of protein phosphatase 5 (PP5) in mediating corticosteroid insensitivity in airway smooth muscle (ASM) cells in severe asthma
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015

Give me the patient's smooth muscle cells and I will tell you how to develop effective anti-asthma therapy – Pro
Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease
Year: 2006


Ionic mechanisms and Ca2+ handling in airway smooth muscle
Source: Eur Respir J 2007; 30: 114-133
Year: 2007



IL33 and TNFalpha synergistically enhance store operated Ca2+ entry in cultured human airway smooth muscle cells
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013


Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

A functional role for WNT-5A in driving airway myocyte proliferation
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013


The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta2-adrenoceptor agonists in airway smooth muscle
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013


Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease?
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013


Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM)
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015

Extracellular matrix within the airway smooth muscle layer correlates with age but not in cases of asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

Integrins regulate eosinophil adhesion to the airway smooth muscle cells in asthma patients
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015

Eosinophil-induced airway smooth muscle cells remodeling is attenuated by blocking of RGD-binding integrins in asthma
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016

The extracellular matrix deposited by asthmatic airway smooth muscle cells in a resting state reflects a healthy matrix
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015


DP2/CRTh2 is expressed by ASM cells in asthma and its inhibition suppresses ASM migration
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

Caveolin-1 regulation of store-operated Ca2+ influx in human airway smooth muscle
Source: Eur Respir J 2012; 40: 470-478
Year: 2012



Effect of oxidative stress on mitochondrial function in airway smooth muscle (ASM) cells from COPD patients
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

LATE-BREAKING ABSTRACT: The long intergenic non-coding RNA, PVT1, regulates the TGF-beta-induced proliferative response in airway smooth muscle cells from severe asthmatics
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013


BioPhysical bronchodilator: A new class of respiratory drug
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


TGF-beta alters TRPC6 expression and calcium handling via smad2/3 in human airway smooth muscle
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013